Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
close

SYNAGIS - 50mg/0.5ml - 1x0.5ml

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
J06BD01 BioTech Palivizumab - 50mg/0.5ml 11749 104121/1 SYNAGIS 50mg/0.5ml 1x0.5ml Injectable solution IM Omnipharma Boehringer Ingelheim Pharma GmbH & Co KG Germany 6,268,896 L.L 19.35 D AstraZeneca AB Sweden 2/5/2024

Drugs With Same Ingredients

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
J06BD01 BioTech Palivizumab - 50mg/0.5ml 11749/945 104121/1 SYNAGIS 50mg/0.5ml 1x0.5ml Injectable solution IM Omnipharma Boehringer Ingelheim Pharma GmbH & Co KG Germany 38,316,693 L.L 19.35 D AstraZeneca AB Sweden 2/5/2024 0
Sitemap
© Copyrights reserved to Ministry of Public Health 2024